Literature DB >> 4196433

The kinetics of the killing of mouse tumour cells in vivo by immune responses.

D D Porteous, T R Munro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4196433     DOI： 10.1002/ijc.2910100115

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  6 in total

1.  Evaluation of host immunity in human neoplasia. II. Discussion.

Authors: 
Journal:  Br J Cancer Suppl       Date:  1973-08

2.  Tumour-cell killing by X-rays and immunity quantitated in a mouse model system.

Authors:  D D Porteous; K M Porteous; M J Hughes
Journal:  Br J Cancer       Date:  1979-05       Impact factor: 7.640

3.  Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.

Authors:  S T Sonis; R Falcão; I C MacLennan
Journal:  Br J Cancer       Date:  1977-09       Impact factor: 7.640

4.  Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour.

Authors:  D M Chassoux; F M Gotch; I C MacLennan
Journal:  Br J Cancer       Date:  1978-08       Impact factor: 7.640

5.  Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo.

Authors:  V J Richardson; B E Ryman
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

6.  Intense tumour-cell destruction by syngeneic mice: role of macrophages, complement activation and tumour-cell factors.

Authors:  S Orbach-Arbouys; J Lheritier; M Allouche; P Pouillart
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.